News

Apple faces Massimo in court: ‘W1 an Apple Watch clone’

Apple and Massimo They make themselves the heroes of one novel legal battle Somewhat interesting: in the past few years, Masimo has sued Apple for stealing key employees from it and misusing its resources and patents in general to make the Apple Watch, while Apple is now resisting by saying that the Masimo medical smartwatch, called the W1, is in Actually a replica of the Apple Watch. Perhaps the best way to summarize the highlights of the conflicting relationship between the two companies is by going through the bullet points:

  • 2013 – Apple requests to meet Massimo for potential collaboration. To put it in context, we’re about two years away from the release of the first generation Apple Watch.
  • 2013/2014 – Apple hires several employees of Masimo and its subsidiary Cercacor, including medical expert Michael O’Reilly
  • 2014 – already at that time, in an interview with ReutersMasimo CEO Joe Kiani publicly accuses Apple of stealing vast amounts of technology, knowledge, and “trade secrets” from it and its employees.
  • 2020 – Massimo sues Apple for infringing 10 patents, saying in the complaint that 2013 meetings organized by Apple worked to identify and stole key employees. The goals are to prevent future uses of its patents, return confidential information and pay compensation.
  • August 2022 – Massimo Massimo W1 launched, a smartwatch with powerful medical features, including continuous tracking of various vital parameters including blood oxygen saturation, pulse, respiratory rate, and hydration index in some markets. This is the company’s first product, very well established and important in the medical sector, aimed at the end consumer.
  • October 20, 2022 – Apple deplores Massimo Claiming that the W1 is in fact a “clone” of the Apple Watch: “Instead of independently inventing and developing a product, Masimo cloned Apple while filing complaints aimed at removing the Apple Watch from the market,” the lawsuit says. The response from Masimo spokesmen was short-lived:

Today’s Apple stock is a desperate attempt by the world’s largest company to divert attention from Massimo’s lawsuit. The truth is that the practice of intellectual property theft rather than fair competition is well established at Apple.

  • October 20, 2022 – On the same day, Apple deposited a second complaint against Massimo, accusing it of infringing five patents, as well as heavily imitating the shape and design of the watch.

It’s certainly not likely that Apple will win a design lawsuit – the rectangular watch leaves little room for the imagination, after all – but the outcome may be less clear when it comes to technologies and patents.

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button